Clinical Study

Does Radioiodine Therapy in Patients with Differentiated Thyroid Cancer Increase the Frequency of Another Malignant Neoplasm?

Table 1

Clinical, epidemiological, and therapeutic characteristics of 168 patients with differentiated thyroid carcinoma (DTC).

Clinical, epidemiological, and therapeutic characteristics

Females n (%)Female: 142 (84.7)
Age* (years)45.15 ± 15.32
Follow-up period** (months)77.5 (1; 468)
Papilliferous carcinoma n (%)137 (81.5)
Radioiodine therapy n (%)160 (95.2)
Radioiodine dose** (mCi)200 (30; 870)
Another neoplasia n (%)15 (8.93)

*mean ± standard deviation; **median (minimum value; maximum value).